1.695
price up icon0.55%   0.005
 
loading
Precedente Chiudi:
$1.69
Aprire:
$1.68
Volume 24 ore:
24,993
Relative Volume:
0.02
Capitalizzazione di mercato:
$188.40M
Reddito:
$34.16M
Utile/perdita netta:
$-50.62M
Rapporto P/E:
-3.3366
EPS:
-0.508
Flusso di cassa netto:
$703.00K
1 W Prestazione:
+6.87%
1M Prestazione:
+27.77%
6M Prestazione:
-52.67%
1 anno Prestazione:
-54.93%
Intervallo 1D:
Value
$1.675
$1.70
Intervallo di 1 settimana:
Value
$1.555
$1.725
Portata 52W:
Value
$1.22
$4.96

Omniab Inc Stock (OABI) Company Profile

Name
Nome
Omniab Inc
Name
Telefono
510-250-7800
Name
Indirizzo
5980 HORTON STREET, EMERYVILLE
Name
Dipendente
114
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
OABI's Discussions on Twitter

Confronta OABI con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
OABI
Omniab Inc
1.695 188.40M 34.16M -50.62M 703.00K -0.508
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
443.57 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
526.82 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
318.52 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.50 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
240.15 28.51B 3.81B -644.79M -669.77M -6.24

Omniab Inc Stock (OABI) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-11-29 Iniziato RBC Capital Mkts Outperform
2023-04-21 Iniziato The Benchmark Company Buy
2023-04-13 Iniziato Craig Hallum Buy
2023-02-22 Iniziato Cowen Outperform
2023-02-13 Iniziato H.C. Wainwright Buy
2022-12-20 Iniziato Truist Buy
2022-12-16 Iniziato Credit Suisse Outperform
2022-11-29 Iniziato SVB Leerink Outperform
2022-11-28 Iniziato Stifel Buy
Mostra tutto

Omniab Inc Borsa (OABI) Ultime notizie

pulisher
Jun 18, 2025

OmniAb Elects Directors at Annual Shareholder Meeting - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

OmniAb shareholders elect two directors at annual meeting - Investing.com

Jun 18, 2025
pulisher
Jun 11, 2025

OmniAb Inc Inc. (OABI) Price Performance: A Fundamental Analysis Perspective - investchronicle.com

Jun 11, 2025
pulisher
Jun 09, 2025

OmniAb, Inc. (NASDAQ:OABI) Shares Acquired by Squarepoint Ops LLC - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

Millennium Management LLC Buys 61,993 Shares of OmniAb, Inc. (NASDAQ:OABI) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

June 2025's Promising Penny Stocks to Consider - Yahoo Finance

Jun 06, 2025
pulisher
Jun 06, 2025

OmniAb, Inc. (NASDAQ:OABI) Stake Cut by Jane Street Group LLC - Defense World

Jun 06, 2025
pulisher
Jun 04, 2025

AI Is Rewiring Healthcare Faster Than Expected — Investors Are Hunting for Public Winners Now - The Globe and Mail

Jun 04, 2025
pulisher
Jun 04, 2025

Delek Logistics Partners, LP Increases Quarterly Cash Distribution to $1.025 per Common Limited Partner Unit - The Globe and Mail

Jun 04, 2025
pulisher
Jun 03, 2025

OmniAb, Inc. (NASDAQ:OABI) Shares Purchased by ProShare Advisors LLC - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

BNP Paribas Financial Markets Buys Shares of 17,549 OmniAb, Inc. (NASDAQ:OABI) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Bank of America Corp DE Has $2.18 Million Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World

Jun 03, 2025
pulisher
May 30, 2025

OABI stock touches 52-week low at $1.25 amid market challenges - Investing.com Australia

May 30, 2025
pulisher
May 30, 2025

OABI stock touches 52-week low at $1.25 amid market challenges By Investing.com - Investing.com South Africa

May 30, 2025
pulisher
May 24, 2025

Northern Trust Corp Acquires 45,169 Shares of OmniAb, Inc. (NASDAQ:OABI) - Defense World

May 24, 2025
pulisher
May 23, 2025

Deutsche Bank AG Increases Stake in OmniAb, Inc. (NASDAQ:OABI) - Defense World

May 23, 2025
pulisher
May 23, 2025

Deal Watch: QurAlis Targets Fragile-X Syndrome In Deals With Quiver, UMass - insights.citeline.com

May 23, 2025
pulisher
May 20, 2025

OmniAb’s SWOT analysis: antibody discovery firm’s stock faces growth opportunities amid market challenges - Investing.com Canada

May 20, 2025
pulisher
May 19, 2025

OmniAb Inc (NASDAQ: OABI) Could Pass $4 In One Year Stock Forecast - Stocksregister

May 19, 2025
pulisher
May 19, 2025

Insider Spends US$94k Buying More Shares In OmniAb - simplywall.st

May 19, 2025
pulisher
May 19, 2025

Chairman of OmniAb Picks Up 3.0% More Stock - Yahoo Finance

May 19, 2025
pulisher
May 19, 2025

51,159 Shares in OmniAb, Inc. (NASDAQ:OABI) Purchased by Balyasny Asset Management L.P. - Defense World

May 19, 2025
pulisher
May 18, 2025

Price T Rowe Associates Inc. MD Has $136,000 Stock Position in OmniAb, Inc. (NASDAQ:OABI) - Defense World

May 18, 2025
pulisher
May 17, 2025

Leerink Partnrs Has Bullish Forecast for OmniAb Q2 Earnings - Defense World

May 17, 2025
pulisher
May 16, 2025

Insider Buying: Jennifer Cochran Acquires 30,000 Shares of OmniA - GuruFocus

May 16, 2025
pulisher
May 15, 2025

Director Makes Bold Move with Major OmniAb Stock Purchase - TipRanks

May 15, 2025
pulisher
May 15, 2025

Insider Buying: Steven Love Acquires 25,000 Shares of OmniAb Inc (OABI) - GuruFocus

May 15, 2025
pulisher
May 14, 2025

Director’s Bold Move: A Major Investment in OmniAb Stock - TipRanks

May 14, 2025
pulisher
May 14, 2025

Insider Buying: John Higgins Acquires 65,000 Shares of OmniAb In - GuruFocus

May 14, 2025
pulisher
May 13, 2025

OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Hsbc Holdings PLC Makes New Investment in OmniAb, Inc. (NASDAQ:OABI) - Defense World

May 13, 2025
pulisher
May 13, 2025

OmniAb’s (OABI) “Buy” Rating Reaffirmed at Benchmark - Defense World

May 13, 2025
pulisher
May 12, 2025

OmniAb: Too Much Risk, Not Enough Reward (NASDAQ:OABI) - Seeking Alpha

May 12, 2025
pulisher
May 11, 2025

OmniAb, Inc. (NASDAQ:OABI) Q1 2025 Earnings Call Transcript - MSN

May 11, 2025
pulisher
May 11, 2025

OmniAb : May 2025 Corporate Overview - marketscreener.com

May 11, 2025
pulisher
May 11, 2025

Earnings Release: Here's Why Analysts Cut Their OmniAb, Inc. (NASDAQ:OABI) Price Target To US$7.88 - simplywall.st

May 11, 2025
pulisher
May 11, 2025

Dimensional Fund Advisors LP Increases Position in OmniAb, Inc. (NASDAQ:OABI) - Defense World

May 11, 2025
pulisher
May 10, 2025

RBC Capital Remains a Buy on OmniAb (OABI) - The Globe and Mail

May 10, 2025
pulisher
May 09, 2025

OmniAb, Inc. (OABI) Reports Q1 Loss, Misses Revenue Estimates - MSN

May 09, 2025
pulisher
May 09, 2025

OmniAb’s Earnings Call: Growth Amid Challenges - TipRanks

May 09, 2025
pulisher
May 09, 2025

OmniAb Introduces the xPloration® Partner Access Program - BioSpace

May 09, 2025
pulisher
May 09, 2025

OmniAb Q1 2025 slides: Revenue growth and pipeline expansion amid cost controls By Investing.com - Investing.com South Africa

May 09, 2025
pulisher
May 09, 2025

Is OmniAb, Inc. (OABI) the Low Risk High Reward Stock Set to Triple by 2030? - Insider Monkey

May 09, 2025
pulisher
May 09, 2025

OmniAb Introduces the xPloration(R) Partner Access Program - marketscreener.com

May 09, 2025
pulisher
May 09, 2025

OmniAb Reports Steady Growth in Q1 2025 - TipRanks

May 09, 2025

Omniab Inc Azioni (OABI) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Omniab Inc Azioni (OABI) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Love Steven
Director
May 14 '25
Buy
1.46
25,000
36,500
38,333
HIGGINS JOHN L
Director
May 12 '25
Buy
1.44
65,000
93,600
2,831,887
FOEHR MATTHEW W
President and CEO
Apr 07 '25
Option Exercise
0.00
36,458
0
3,815,618
FOEHR MATTHEW W
President and CEO
Apr 07 '25
Sale
2.00
19,382
38,764
3,796,236
Berkman Charles S
Chief Legal Officer
Apr 07 '25
Option Exercise
0.00
13,542
0
370,418
Berkman Charles S
Chief Legal Officer
Apr 07 '25
Sale
2.00
7,206
14,412
363,212
GUSTAFSON KURT A
Executive VP, Finance and CFO
Apr 07 '25
Option Exercise
0.00
13,542
0
231,034
GUSTAFSON KURT A
Executive VP, Finance and CFO
Apr 07 '25
Sale
2.00
7,206
14,412
223,828
$20.42
price down icon 1.37%
$35.45
price up icon 0.65%
$21.06
price down icon 1.92%
$101.83
price down icon 0.41%
$105.86
price down icon 0.39%
biotechnology ONC
$244.00
price down icon 3.69%
Capitalizzazione:     |  Volume (24 ore):